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Viral infections affect millions around the world, sometimes leading to sever
consequences or even epidemics. Understanding the molecular dynamics during vir
infections would provide crucial information for preventing or stopping the progress
infections. However, the current methods often involve the disruption of the infecte
cells or expensive and time-consuming procedures. In this study, fluorescent polymeri
nanoparticles were fabricated and used as bioimaging nanoprobes that can monitor th
progression of influenza viral infection through the changes in the expression levels
sialic acids expressed on the cell membrane. The nanoparticles were composed of
biocompatible monomer to prevent non-specific interactions, a hydrophobic monom
to form the core, a fluorescent monomer, and a protein-binding monomer to conjugat
lectin, which binds sialic acids. It was shown that these lectin-tagged nanoparticles th
specifically target sialic acids could track the changes in the expression levels of siali
acids caused by influenza viral infections in human lung epithelial cells. There was
sudden drop in the levels of sialic acid at the initial onset of virus infection (t = 0∼1 h) an
at approximately 4∼5 h post-infection. The latter drop correlated with the productio
of viral proteins that was confirmed using traditional techniques. Thus, the accurac
the rapidity and the efficacy of the nanoprobes were demonstrated. Such molecul
bioimaging tools, which allow easy-handling and in situ monitoring, would be useful t
directly observe and decipher the viral infection mechanisms.
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INTRODUCTION
Recently, viral infection has been a major global issue due to the dangers associated with the high
death ratio and secondary diseases (Sun et al., 2011; Chen et al., 2012; Sichelstiel et al., 2014),
also causing chronic infections in the case of negligence (Landford et al., 2010; Jacobson et al.,
2011; Chen et al., 2013). However, the molecular interactions and mechanisms behind these viral
infections have not been clarified. Many types of analytical methods have been developed for
viral infection such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay
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(ELISA), but these assays involve disruptive cell lysis processes
with expensive reagents due to the complicated nature of these
protocols. In order to enable a detailed analysis and develop a
deeper understanding of the viral infection process, it is necessary
to develop a novel analytical system compatible with living cells.
During viral infection of cells, sialic acids on the cell
membrane, which are oligosaccharides with glycoproteins and
glycolipids, play essential roles. The influenza viral infection
proceeds through the attachment of hemagglutinins (HA) on the
viral membrane to sialic acids (de Lima et al., 1995; Fukuzawa
et al., 2011; Lai et al., 2012; Zhu et al., 2012). HA is a viral coat
glycoprotein, which binds to specific sialic acid receptors in the
respiratory tract for penetration into the cell (Connor et al., 1994;
Kuiken et al., 2006; Maines et al., 2009). In particular, specific
kinds of influenza virus are associated with specific sialic acid
binding and modifications for their pathogenic pathway, as well
as the types of HA. When the influenza viruses penetrate into
the cells for the infection, HA of the virus recognizes and binds
to sialic acid on the cell membrane, and so, the expression level
of sialic acid on the host cell is affected by viral infection (Ueda
et al., 2013). Lectin, a class of carbohydrate-binding proteins,
has high specificity for the specific sialic acid bound with other
biomolecules. For example, Sambucus nigra barks lectin (SNA)
can specifically recognize α-2,6-sialic acid and this type of sialic
acid is known to be part of a recognizable glycan for binding
by HA on viruses. To analyze the receptor-binding preferences,
recognition mechanisms and changes in the expression levels of
reacted sialic acids, it is necessary to assess the in situ changes in
the cell membrane structures, such as glycans.
Recently, there have been multiple advances in bioimaging
techniques to monitor cells using fluorescent nanoparticles,
and they offer multiple advantages such as the capacity
for real-time, non-disruptive monitoring of individual cells
and ease of handling (Goto et al., 2008; Wolfbeis, 2015).
In particular, a polymeric-nanoparticle-based bioimaging
platform that can specifically and sensitively measure
sialic acid levels have been developed (Cho et al., 2014).
More specifically, this biocompatible bioimaging nanoprobe
consist of 2-methacryloyloxyethyl phosphorylcholine (MPC),
n-butyl methacrylate (BMA), o-nitrophenyloxycarbonyl
polyethleneglycol methacrylate (MEONP), p-methacyloxyethyl
thiocarbonyl rhodamine B (MTR), and lectin. MPC polymers
prevent protein adsorption and thus makes the nanoprobe
bioinert to most biomolecules (Moro et al., 2004; Goda et al.,
2009). BMA is highly hydrophobic and thus, in conjunction
with polylactic acid (PLA) forms the hydrophobic core of the
nanoparticle. MEONP contains active ester groups that can
conjugate other biomolecules, which in this case is streptavidin
that subsequently bind the biotinylated lectin. MTR contains
Rhodamine B, which have been safely used for the detection
of mitochondria in the living cell in other bioimaging probes
(Johnson et al., 1980). In this study, using these lectin-conjugated
fluorescent polymeric nanoparticles as nanoprobes, simple
and rapid analysis of sialic acid on the cell membrane were
performed by tracking the fluorescence of the nanoprobes on
the cells. This nanoprobe system was compared to some of the
traditional methods to detect sialic acids, and it was suggested
that these nanoprobes can be applied as a quick and reliable in
situ bioimaging technology for the early detection of the changes
in sialic acids and to further understand the process of viral
infections.
MATERIALS AND METHODS
Reagents
Biotinylated Sambucus nigra barks lectin was purchased from
Vector Laboratory (Burlingame, U.S.A). Phenylmethylsulfonyl
fluoride (PMSF) was purchased from Calbiochem (Darmstadt,
Germany). Anti-PB1 antibody was prepared by immunization of
rabbit with purified PB1 protein. 4′,6-diamino-2-phenylindole
(DAPI), rabbit immunoglobulin G (IgG) antibody and mouse
IgG antibody with Alexa Flour 488 were purchased from
Invitrogen (Carlsbad, CA, U.S.A). Ethylenediamine-N,N,N′,N′-
tetraacetic acid (EDTA), N-cyclohexyl-3-aminopropanesulfonic
acid (CAPS) and HEPES buffer solution were purchased
from Dojindo (Kumamoto, Japan). Blocking one solution
and Tris(hydromethyl) amino methane (Tris-base) were
purchased from Nacalai tesque (Kyoto, Japan). Acrylamide,
N′,N′-methylene bis(acrylamide) (bis), ammonium persulfate
(APS), sodium dodecyl sulfate (SDS), paraformaldehyde (PFA)
were purchased from Wako Pure Chemical Industries Co., Ltd.
(Osaka, Japan). The details of the other reagents used for the
nanoprobe fabrication and the cell probing are described in the
previous study (Cho et al., 2014).
Fabrication of Bioimaging Nanoprobes
The details of the fabrication process of the nanoprobes, as well
as their chemical and physical characterizations, are described in
the previous study (Cho et al., 2014). Briefly, the polymer base
of the nanoprobe was synthesized via free radical polymerization
by combining MPC, BMA, MEONP, and MTR monomers
with α-2,2′-Azobisisobutyronitrile (AIBN), dissolved in degassed
ethanol at 0.5 M for the monomers and 10 mM for AIBN.
The solution was reacted in the oil bath at 65◦C for 15 h then
precipitated in the 8:2 (v/v ratio) mixture of diethylether and
chloroform, respectively.
For the formation of the nanoparticles, the solvent
evaporation technique (Goda et al., 2009) was utilized and
lectin was subsequently conjugated. Briefly, 0.1 wt% of PLA in
dichloromethane solution wasmixed with 0.1 wt% of the aqueous
polymer solution, and under the stirring condition at 400 rpm
and 0◦C, the mixture was sonicated using a probe-type sonicator
(VP-5S, TAITEC, Japan) for 5 min. The formed nanoparticles
were collected by an ultracentrifuge (XL-A, Beckman Coulter,
U.S.A.) ran at 50,000 rpm at 4◦C for 2 h, and lastly dispersed
in deionized water. For the immobilization of lectins onto
the nanoparticle surfaces to complete the nanoprobes, the
nanoparticles at 10 mg/mL were first reacted with streptavidin
at 10 µg/mL for 3 h, which in turn was conjugated with 10
µg/mL biotinylated SNA lectin for 3 h. In each reaction step, the
products were collected by centrifugation at 50,000 rpm at 4◦C
for 2 h. It should also be noted that the modular design of the
nanoprobe enables conjugation of different bioactive molecules
to MEONP for various applications.
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Cell Culture and Viral Infection
For cell culturing of human lung epithelial cell (H292 from
American Type Culture Collection), the E-MEM, and EDTA
solution were prepared. 9.8 g of E-MEM was added in 900 mL
of deionized water. The solution was autoclaved for sterilization.
After cooling of the autoclaved solution at the room temperature,
FBS, L-glutamine and 7.5% of NaHCO3 were added in the
solution. 7.5% of NaHCO3 was filtered with 0.2 µm of filter.
In the serum-free E-MEM, other components except FBS were
added. Two types of EDTA solution were prepared: 0.4% in water
and 0.04% in DPBS.
To infect influenza virus into the cells, 3 × 104 cells/well
of H292 cells were cultured in the glass-bottom 96 well
overnight. The cultured cells were washed with serum-free E-
MEMmedium. The washed cells were pre-incubated in 50 µL of
the viral solution (multiplicity of infection of 1) for 1 h at 34◦C.
The solution included PR8 influenza A virus (H1N1) strain in
the serum-free E-MEM. After pre-incubation, 100 µL of E-MEM
mediumwas added in the dish. In themedium, the pre-incubated
cells were cultured for infection at 34◦C from 1 to 5 h.
Western Blotting and Dot Blot Assay for
Detecting the Expression Level of Sialic
Acid
For the Western blotting on the PVDF membrane, the cell
proteins were extracted by cell lysis. Both the virus-infected and
uninfected cells were cultured and sonicated five times for 10 s
after addition of 0.1 M phenylmethanesulfonyl fluoride with
the extraction buffer. The proteins of the sonicated cells in the
solution were separated by centrifugation (15,000 rpm, 4◦C, 30
min). The collected cell proteins were heated at 95◦C for 3
min, and then the electrophoresis was performed. The samples
including cellular proteins were separated on the SDS-PAGE at
30 mA for 1 h and soaked in 10 mMCAPS buffer containing 10%
methanol (pH 11) for 20 min. The concentration of CAPS buffer
(pH 11) was 0.01 M in deionized water (60-fold diluted from the
original solution). After treatment with the membrane in CAPS
buffer for 20 min, the sample was blotted by the electrophoresis
on PVDF membrane (Nippon Genetics) at 4◦C for 1 h. Then,
the membrane was treated in the blocking one solution at
37◦C for 30 min. On the membrane with cell proteins for
various cell concentrations, 10 µg/mL of biotinylated SNA lectin
were reacted for 12 h at the room temperature. After washing
with DPBS twice in the rotary shaker (NA-301, Nissin, Tokyo,
Japan) for 10 min, 10 µg/mL of Alexa-Fluor-488-conjugated
streptavidin was reacted on the lectin-immobilized membrane
for 12 h at the room temperature. The fluorescence images of the
reacted membrane was washed with DPBS twice in the shaker
for 10 min, and observed by image analyzer (Typhoon9410, GE
Healthcare Life Sciences, Buckinghamshire, U.K.).
For the dot blot assay, attached cells in the dish were removed
by treatment with trypsin. Removed cells were harvested by
centrifugation at 700 rpm for 5 min at 4◦C. The cell pellet was
disrupted by adding glass beads in 100 µL Milli-Q water and
centrifuged at 6500 rpm using Precelly 24 (Bertin, Provence,
France) for 20 s, and placed on ice for 5 s. The disruption of cells
was completed after 7 cycles. After the disruption of the cells, the
supernatant was harvested by centrifugation at 15000 rpm for 5
min at 4◦C and treated with trypsin adjusted to 0.01% for 30 min
at 37◦C. The supernatant equivalent to 105 cells was dotted on
the PVDF membrane, reacted with lectin and detected with the
chemiluminescence using the luminescent image analyzer.
Bioimaging of the Expression Level of
Sialic Acid on the Virus-Infected Cells
Using Nanoprobes
Before the cellular experiment, H292 cells infected with influenza
virus were incubated from 1 to 5 h at 34◦C in the glass bottom
96-well plate with 100 µL of E-MEMmedium. On the cells in the
well plate, 10 µL of nanoprobe solution were added and reacted
with H292 for 15 min at 34◦C, respectively. The cells were then
washed with PBS three times at room temperature, and then
observed at 100x magnification using a fluorescence microscope
(Nikon TiEmicroscope, Japan). The fluorescence intensities were
quantified to determine the levels of sialic acid expression levels
on the infected cells.
For the fixation of the cells to check HA expression, the
influenza virus infected cells were washed twice with PBS at room
temperature and fixed with 4% paraformaldehyde (PFA) for 15
min. After fixation, the cells were washed three times with PBS
followed by reaction with anti-HA IgG (mouse) solution at 37◦C
for 1h. The cells were then washed with PBS three times at room
temperature, reacted with anti-mouse IgG (rabbit) conjugated
with Alexa 488 for 1 h at 37◦C, observed at 100x magnification
using the fluorescence microscope.
Immunostaining for the Confirmation of
Viral Protein Production
To demonstrate viral infection on the cells, immunostaining was
performed. The virus-infected cells for various infection times
were fixed using 100 µL of 4% paraformaldehyde in DPBS at
room temperature for 15 min. Then, 100 µL of 0.1% of Triton
X-100, a kind of detergent, in DPBS was reacted to permeabilize
virus-infected cells for 5 min. After the reaction, the cells were
incubated with 100 µL of 3% bovine serum albumin (BSA)
in DPBS at the room temperature for 30 min. Then, the cells
were reacted with 50 µL of 3% BSA solution including PB1/HA
protein antibody at room temperature for 1 h. To perform
fluorescent assay, the washed cells were reacted with Alexa-Fluor-
488-conjugated rabbit IgG secondary antibody in 50 µL of 3%
BSA solution at room temperature for 1 h. DAPI staining for the
cell nucleus was also performed prior to the observation with the
microscope. The reacted cells were washed five times with 100µL
of DPBS between each steps. The antibody-conjugated cells were
observed using the fluorescence microscope.
Real Time Polymerase Chain Reaction
(RT-PCR) for the Confirmation of
Transcription of Viral Protein Genes
Total RNA was extracted from 105 influenza virus-infected
cells at each time point post-influenza virus infection using
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Qiagen RNeasy kit (Qiagen, USA). Primer sequences for RT-
PCR were designed for the RNA 2 segment, which encodes
PB1, a critical subunit of viral RNA polymerase. Forward primer
was 5′-ACCGGAGACCCTCCTTACAGCC, reverse primer was
5′- TCGGGTTGAGTTGCGGTGCT. Then RT-PCR assay was
performed using primers for RNA 2 segment. The emission
from SYBR Green, a nucleic acid stain, was detected using
an Applied Biosystems 7500 Real Time PCR System (Applied
Biosystems, USA).
RESULTS
Western Blotting to Identify the Detection
Levels of α-2,6-Sialic Acid Using
Lectin-Fluorescence
Prior to the nanoprobe experiments on living cells, the presence
and the relative amount of α-2,6- sialic acids in the H292
cells were examined using the traditional Western blotting
approach. The blot was visualized using fluorescently-tagged
streptavidin to perform Western blotting (Figure 1A). It was
shown that the different concentrations of cellular proteins were
transferred onto the PVDF membrane, and the signal intensity
was confirmed to increase in proportion to the cell number.
Below 1 × 104 cells, the fluorescence intensity was sharply
decreased, while above 5 × 104 cells, the signal seemed to be
saturated. Thus, for the subsequentWestern blotting analysis, the
optimal range of cell number to investigate the levels of sialic
acid of H292 cells using lectin was calibrated to be between these
numbers.
Next, the dot blot assay was performed using 2 × 104
cells/dot to determine the relative amounts of sialic acid in
the H292 cells at different time points after viral infection
(Figure S1). The result showed that the amount of sialic acid
in cells decreased in a step-wise fashion over time as the viral
infection progressed, ultimately falling below 50% compared to
the non-infected cells at 4 h post-infection (hpi) (Figure 1B).
Also, the decrease in sialic acid level was detected as early as 1 hpi,
suggesting that the virus entry into the cells may partially halt the
production of sialic acid within an hour. Although the data were
normalized to the non-infected control samples resulting in high
variance, it was suggested that these differences were significant
(Figure S2).
Bioimaging of the Expression Levels of
α-2,6-Sialic Acid on the Membrane of the
Virus-Infected Cells Using Nanoprobes
Next, the novel approach to detect the expression levels of the
sialic acid on the virus-infected cells through bioimaging with
the nanoprobes was tested (Figure 2). The specificity of these
nanoprobes to α-2,6-sialic acid has already been confirmed in the
previous study; when cells were pretreated with various sialidases
that cleave sialic acids, the nanoprobes did not bind to the
cells (Cho et al., 2014; Fujii et al., 2016). Furthermore, it was
demonstrated that the lectins tethered to the nanoparticles have
enhanced affinity for sialic acid compared to bare, fluorescently-
tagged lectins (Figure S3), presumably due to the enhanced
avidity of havingmultiple lectins on the nanoprobe surface. Thus,
rapid and efficient analysis of sialic acid on the cell membrane was
enabled, and the expression level of α-2,6-sialic acid on the cell
membrane was analyzed during the viral infection time from 0 to
5 hpi. These nanoprobes bound the α-2,6-sialic acids and allowed
the observations of the changes in the expression levels of the
sialic acids by infection time (Figure 3A). The expression level
of sialic acid was sharply decreased from immediately (0 h) after
the infection, and followed a gradual decline thereafter (1∼5 h).
Also, HA expression on the cell was observed by immunostaining
FIGURE 1 | The Western blot analyses of extracted α-2,6-sialic acids visualized using tagged-SNA lectins. (A) Western blotting with different numbers of
cells was performed to determine the optimal, non-saturating signals. (B) The quantification of the normalized chemiluminescence signals of the sialic acids are
shown. Result for the control without viral infection (–) is also shown and the data set was normalized to the control.
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FIGURE 2 | The schematics of the experimental design (A), the design of the nanoprobe to detect sialic acids (B) and the chemical structures of the
incorporated functional monomers (C).
using FITC-conjugated anti-HA antibody (Figure 3A, 5 hpi),
confirming the influenza virus infection.
To quantify the expression level of each sialic acid on the
membrane of the virus-infected cells via the nanoprobes, the
fluorescence intensities of 50 randomly-picked, representative
cells were analyzed. The result showed the quantitative changes
of the expression level of sialic acid against viral infection
time (Figure 3B). For α-2,6-sialic acid, there was indeed a
sharp decrease in fluorescence immediately after the infection
and also at 5 h post-infection. Although the data were
normalized to the non-infected control samples resulting in high
variance, it was suggested that these differences were significant
(Figure S4).
It is also important to note that nanoprobes are mostly taken
up by the cells through endocytosis, as suggested by the fact
that the decrease in temperature (to 4◦C) causes a sharp decline
in the uptake of nanoprobes (Figure S5), presumably due to
the loss of fluidity of the membrane. The role of endocytosis
was further confirmed using endocytosis inhibitors, such as
nystatin and chlorpromazine, which suppressed the nanoprobe
intensities to roughly 70 and 50% of the non-treated cells,
respectively (data not shown). Thus, the observed nanoprobe
fluorescence represent both the surface sialic acids on the outer
cell membrane, as well as the endocytosed sialic acids, but not the
newly synthesized sialic acids that are not membrane bound.
Confirmation of the Production of Viral
Proteins in the Cells through RT-PCR and
Immunostaining
To analyze the actual virus activity within the virus-infected
cells and correlate it to the expression levels of the sialic
acid, the influenza A virus were pre-incubated with cells for
1 h and the subsequent production of the viral proteins
within the cells were analyzed. As before, the expression
levels of sialic acid on the virus-infected cells were analyzed
using lectin-conjugated polymeric nanoparticles. The production
of the viral protein PB1, a crucial component of the viral
RNA polymerase, was tracked at the level of transcription
and translation. Thus, in parallel with the analysis of the
expression levels of sialic acid on the incubated cells with viruses
using lectin-conjugated polymeric nanoparticles, the analysis
of viral protein production were performed by RT-PCR and
immunostaining.
First, RT-PCR for mRNA of PB1 was performed to confirm
that the observation of sialic acid expression level obtained
from the previous time-lapse data was due to the actual viral
infection. From the RT-PCR data, the transcription of mRNA
coding PB1 was analyzed against viral infection time (Figure 4).
It was observed that the expression of mRNA of PB1 gene began
to rise at past 5 h of viral infection and rapidly increased over
time (Table S1). The time-course of PB1 mRNA production as
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FIGURE 3 | The detection of membrane-bound α-2,6-sialic acids visualized using the nanoprobes. (A) The fluorescence images of virus-infected H292 cells
reacted with SNA-conjugated fluorescent polymeric nanoparticles [Red; viral infection time from 0 to 5 h post-infection (hpi)]. Controls without viral infection (–V) and
the presence of HA (Green) after the viral infection are also shown. Scale Bar: 20 µm. (B) The normalized fluorescence intensities of virus-infected H292 cells reacted
with SNA-conjugated fluorescent polymeric nanoparticles [viral infection time from 0 to 5 h post-infection (hpi)]. Result for the control without viral infection (–) is also
shown and the data set was normalized to the control.
observed through the RT-PCR experiment was consistent with
the decrease in sialic acid expression levels observed in the
previous experiments.
Furthermore, immunostaining was performed to monitor the
production of PB1 in relations to the sialic acid expression
levels of cells. The immunostaining was performed using anti-
PB1 antibody and the fluorescent nanoparticles (Figure 5).
The virus-infected cells were identified by the DAPI stain
of the nucleus, while PB1 produced by the virus were
tagged with the green fluorescence originating from the
secondary antibody. The red signals from the nanoprobes
seemed to be significantly reduced by the fixation process.
Regardless, it was observed that the production of PB1
started at around 4 h post-infection, and stronger signals
were obtained at 5 h post-infection (Figure S6). Again,
the time-course of PB1 production as observed through the
immunostaining experiment was consistent with the decrease in
sialic acid expression levels observed in the previous experiments.
Furthermore, the relative intensities of the signals showed a
similar trend with the RT-PCR result of PB1 mRNA, where the
production levels of PB1 was minute at 4 h and rose rapidly
at 5 h.
DISCUSSIONS
All in all, the results demonstrate the accuracy and efficiency
of the use of nanoprobes to monitor the changes in sialic acids
during viral infections, which may serve as an indicator of viral
infection progression. Because the change of expression level
of sialic acid on virus-infected cells has not been previously
demonstrated, it was confirmed by the detection of viral
proteins using immunostaining and Western blotting in this
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study. However, it is important to note that the observation
of the expression levels of sialic acid using the nanoprobe is
much simpler and faster than immunostaining and Western
blotting. This bioimaging method, which does not involve
cell lysis protocol or electrophoresis, was performed in less
than 1 h, and it offers the means to observe the changes in
cellular properties in situ. Furthermore, it was found that the
observation of the changes in the expression level of sialic
acid can be observed from 1 h after viral infection, while
the detection of PB1 can only be possible from roughly 5
h after a viral infection, suggesting that earlier detection of
viral infection can be made possible using the nanoprobe
platform.
Some findings in our studies warrant further research and
investigation, such as the immediate decrease in the membrane-
bound sialic acid levels after viral infection observed using
the nanoprobes. To the best of our knowledge, there has not
been any report on this immediate decrease in sialic acids
during virus infections. However, there are various possibilities
for the observed decline in the amount of membrane sialic
acid immediately following virus infection. One possibility is
that the fluidity of the cell membrane may be affected by
virus infection, such that the endocytic process is inhibited,
leading to less overall nanoprobe uptake of the cells. Another
possibility is that the cell cycle progression is halted at G0/G1
phase during Influenza A virus infection, as shown in previous
research (He et al., 2010), whichmay be hindering the production
of sialic acids that generally occur at the end of G2 phase
FIGURE 4 | The RT-PCR analysis of the amounts of mRNA coding for
PB1 in cells with different hours post-infection (hpi).
(Rosenberg and Einstein, 1972). Yet another possibility is that
the process of virus binding itself may be depleting the available
sialic acids on the cell membrane or withholding the endocytosed
sialic acids, leading to the apparent decline in the amount
of sialic acids on the cell membrane as quantified by the
nanoprobe. Any of the above reasons or combinations thereof
may be causing the initial decline in sialic acid levels on the
cell membrane, but these possibilities still have to be further
tested.
Furthermore, differences between the levels of sialic acid on
the membrane of the cells (observed through the nanoprobe) and
that of the entire cell (observed through the Western Blotting)
were found. In particular, the sialic acid levels observed by the
nanoprobe dropped immediately after virus infection, while the
levels from the Dot Blotting dropped about 1 h post-infection.
On the other hand, there was another decline of sialic acid levels
at 4 h observed by Dot Blotting, while the nanoprobe detected
this decline at 5 h. The former may be explained by some of
the explanations listed above regarding endocytosis and receptor
obstruction. The latter decline of the sialic acid will need to be
further investigated, but it may be related to the diversion of
metabolic pathways toward viral proteins instead of the sialic
acids, which had a slightly delayed effect on the cell-surface sialic
acids.
Lastly, the robustness and the generality of this nanoprobe
system for various applications should be discussed. Recently,
the mechanisms between different interactions between viruses
and sialic acids and their structural correlations have become
more apparent (Stencel-Baerenwald et al., 2014). Although
the results here are that of one type of sialic acid and
lectin combination, other forms of sialic acid, such as α-2,3-
sialic acid that specifically interact with Maackia amurensis
II lectin (MAL), should be tested in order to confirm
some of the previous findings and gain further insight into
the changes in sialic acid expressions upon viral infections.
Furthermore, although the influenza virus infection occurs
through the process of sialic acid recognition and the
subsequent uptake of virus particles into the cells, other viruses
often infect through different mechanisms. The nanoprobes
use in this study, comprised of the lectin-tagged polymeric
nanoparticles, contains lectins that recognize sialic acids, but
they can also be conjugated with other molecules to capture
different interactions and properties of the cell membrane
surface, which will not only be useful for studying virus
FIGURE 5 | The fluorescence images of the immunostaining of non-infected cells (–V) and virus-infected cells from 1 to 5 h post-infection (hpi) (Blue:
nucleus; Red: nanoprobes, Green: PB1 viral protein). Scale Bar: 20 µm.
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infections, but also to investigate various cellular functions
as well.
CONCLUSION
In this study, the behaviors of sialic acid on the influenza-
virus-infected cells for viral infection time were analyzed using
various methods. Immediate decline in the sialic acid levels were
observed by the nanoprobe and Dot Blot analyses. After 4∼5 h
post viral infection, the amounts of sialic acid again decreased
sharply, and this was consistent with the initiation of the viral
protein production as confirmed by some of the traditional
analytical methods. With the nanoprobe system, such analyses
and the detection of the sialic acids relevant to virus-infected
cells could be performed quickly, requiring only 15 min for the
reaction with cells. In conclusion, the polymeric nanoparticle
platform offers a rapid and accurate detection of sialic acids on
the cell membrane that may find useful applications in the areas
of disease control and clinical diagnosis in the future.
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